AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2016

May 21, 2016

32870_dirs_2016-05-20_504a6afc-9d87-4620-bcb9-70f597e5525d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2016-05-18

Reporting Person: White Marvin L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-18	Common Stock	D	7833	—	Disposed	22467	Direct

Footnotes

F1: Represents the number of unvested restricted stock units forfeited due to resignation.

F2: The total number of shares has been reduced by 7,833 as a result of the Reporting Person's resignation from the Emergent Board of Directors in connection with his being named as prospective Chief Executive Officer of Aptevo, an entity being spun-off from Emergent.